Business Context and Reporting Period
Company: Kimberly-Clark Corporation (K-C)
Filing Type: Form 8-K (Current Report)
Date of Report: November 2, 2025
Event: Entry into a Material Definitive Agreement (Merger Agreement) with Kenvue Inc. to acquire Kenvue in a stock-and-cash transaction.
Key Financial Metrics and Transaction Terms
Merger Consideration:
- Stock Component: 0.14625 shares of K-C Common Stock for each share of Kenvue Common Stock.
- Cash Component: $3.50 per share of Kenvue Common Stock.
Financing:
- Bridge Facility: $7.7 billion commitment from JPMorgan Chase Bank, N.A. to fund the cash consideration and transaction fees.
- Usage: Available if K-C has not received sufficient proceeds from debt capital markets or other sources prior to closing.
Termination Fee: $1,136,000,000 payable under specific circumstances (e.g., change in recommendation, failure to obtain stockholder approval, or breach in the presence of a superior proposal).
Financial Statements: This filing does not provide current revenue, profit, cash flow, or margin data for Kimberly-Clark or Kenvue. It references historical filings (10-K, 10-Q) for such metrics.
Material Changes and Transaction Structure
Structure:
- First Merger: K-C subsidiary merges with Kenvue; Kenvue survives as a K-C subsidiary.
- Second Merger: The surviving Kenvue entity merges into a second K-C subsidiary; the second subsidiary survives as the final entity.
Board Composition: Effective at closing, the K-C Board will include three designees from Kenvue, with the remainder consisting of existing K-C directors.
Equity Awards: Outstanding Kenvue equity awards will convert to K-C awards. Performance stock units will convert to time-vesting restricted stock units.
Guidance, Outlook, Risks, and Contingencies
Conditions to Closing:
- Stockholder approval from both K-C and Kenvue.
- Regulatory approvals (Hart-Scott-Rodino and foreign antitrust).
- Effectiveness of Form S-4 registration statement.
- Nasdaq listing approval for the stock consideration.
Timeline:
- Outside Date: November 2, 2026 (subject to automatic extension to May 3, 2027, for regulatory approvals).
Risks and Uncertainties:
- Failure to obtain required approvals or stockholder votes.
- Integration risks and potential disruption to operations.
- Realization of anticipated synergies and cost savings.
- Changes in credit ratings or capital market conditions.
- Macroeconomic factors including inflation, currency fluctuations, and supply chain disruptions.
Management Commentary: The filing includes a cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to various risks beyond management's control.
Important Facts for Investor Verification
- Exchange Ratio: Verify the final exchange ratio of 0.14625 K-C shares plus $3.50 cash per Kenvue share.
- Financing Status: Monitor the status of the $7.7 billion bridge facility and whether permanent financing is secured prior to closing.
- Regulatory Approval: Track the status of antitrust reviews and the effectiveness of the Form S-4.
- Stockholder Votes: Confirm the outcome of the stockholder meetings for both companies.
- Termination Fee Triggers: Review the specific conditions under which the $1.136 billion termination fee would be payable.
- Board Changes: Note the addition of three Kenvue designees to the K-C Board upon closing.